NBIX · Company research
Neurocrine Biosciences Inc (NBIX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 143.47 | $13,749,076,000 | 13482576000.00 | 610.6086956521739130 | — | — | 46.4495810810810811 | 4.0350636849210542 | 100.5784637893196749 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.